Kristin L. Komschlies

Author

Frederick National Laboratory for Cancer Research

Also Known As

K L Komschlies, K. Komschlies, K. L. Komschlies, KRISTIN L. KOMSCHLIES, Kristin Komschlies, Kristin L Komschlies, Kristin L. Komschlies

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Frederick National Laboratory for Cancer Research National Cancer Institute Science Applications International Corporation (United States)National Institutes of Health Genesis Laboratories

About

Kristin L. Komschlies is an author at Frederick National Laboratory for Cancer Research specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	854
2	Cell Biology	12	12	781
3	Health Sciences	2	2	85
4	Allergy	2	2	85
5	Cellular Physiology	1	1	48

Kristin L. Komschlies

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP Gregory A. Taylor, Carmen M. Collazo, George Yap, Proceedings of the National Academy of Sciences	2000	269
Studies of thymocytopoiesis in rats and mice. I. Kinetics of appearance of thymocytes using a direct intrathymic adoptive transfer assay for thymocyte precursors. Irving Goldschneider, Kristin L. Komschlies, Dale L. Greiner The Journal of Experimental Medicine Saturation KineticsCell TherapyXenotransplantationI. KineticsLaboratory Immunology	1986	184
Administration of Interleukin 12 With Pulse Interleukin 2 and the Rapid and Complete Eradication of Murine Renal Carcinoma Jon M. Wigginton, Kristin L. Komschlies, Timothy Back, JNCI Journal of the National Cancer Institute	1996	160
Interleukin-7 restores immunity in athymic T-cell–depleted hosts Terry J. Fry, Barbara L. Christensen, Kristin L. Komschlies, Blood	2001	154
IL-7 Administration Alters the CD4:CD8 Ratio, Increases T Cell Numbers, and Increases T Cell Function in the Absence of Activation Lisa Geiselhart, Courtney A. Humphries, T A Gregorio, The Journal of Immunology	2001	139
IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart, Journal of Clinical Investigation	2001	126
Expression of <i>ets</i> genes in mouse thymocyte subsets and T cells. N K Bhat, Kristin L. Komschlies, Shigeyoshi Fujiwara, The Journal of Immunology	1989	121
Gradual Loss of T-Helper 1 Populations in Spleen of Mice During Progressive Tumor Growth Paritosh Ghosh, Kristin L. Komschlies, Marco Cippitelli, JNCI Journal of the National Cancer Institute	1995	119
IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy Jon M. Wigginton, Eilene Gruys, Lisa Geiselhart, Journal of Clinical Investigation Antiangiogenic EffectsImmunologyImmune RegulationCell DeathImmunologic Mechanism	2001	109
Administration of recombinant human IL-7 to mice alters the composition of B-lineage cells and T cell subsets, enhances T cell function, and induces regression of established metastases. Kristin L. Komschlies, T A Gregorio, M. Eilene Gruys, The Journal of Immunology Rhil-7 AdministrationB-lineage CellsLymphocyte DevelopmentT-regulatory CellImmunology	1994	86

Page 1